- Home
- BMR vs MDCX Comparison
BMR vs MDCX Comparison
Compare BMR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- MDCX
- Stock Information
- Founded
- BMR 2009
- MDCX 2008
- Country
- BMR Israel
- MDCX United States
- Employees
- BMR N/A
- MDCX N/A
- Industry
- BMR Computer Software: Prepackaged Software
- MDCX
- Sector
- BMR Technology
- MDCX
- Exchange
- BMR Nasdaq
- MDCX Nasdaq
- Market Cap
- BMR 47.4M
- MDCX 50.8M
- IPO Year
- BMR 2023
- MDCX N/A
- Fundamental
- Price
- BMR $2.15
- MDCX $2.41
- Analyst Decision
- BMR
- MDCX Strong Buy
- Analyst Count
- BMR 0
- MDCX 2
- Target Price
- BMR N/A
- MDCX $23.50
- AVG Volume (30 Days)
- BMR 238.9K
- MDCX 329.5K
- Earning Date
- BMR 08-13-2025
- MDCX 11-22-2025
- Dividend Yield
- BMR N/A
- MDCX N/A
- EPS Growth
- BMR N/A
- MDCX N/A
- EPS
- BMR N/A
- MDCX N/A
- Revenue
- BMR $3,131,000.00
- MDCX N/A
- Revenue This Year
- BMR $21.21
- MDCX N/A
- Revenue Next Year
- BMR N/A
- MDCX N/A
- P/E Ratio
- BMR N/A
- MDCX N/A
- Revenue Growth
- BMR 5.96
- MDCX N/A
- 52 Week Low
- BMR $1.86
- MDCX $1.79
- 52 Week High
- BMR $6.59
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- BMR 30.65
- MDCX 49.72
- Support Level
- BMR $2.26
- MDCX $2.15
- Resistance Level
- BMR $2.90
- MDCX $2.60
- Average True Range (ATR)
- BMR 0.16
- MDCX 0.20
- MACD
- BMR -0.06
- MDCX -0.01
- Stochastic Oscillator
- BMR 3.57
- MDCX 36.52
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.